Clinical trial Recruiting at 1 site Interventional

Online mindfulness program for children with ADHD

Official title: The Effects of an Online Mindfulness-based Intervention for Parents of Children with Attention-Deficit/Hyperactivity Disorder: a Randomized Controlled Trial

Run by The Hong Kong Polytechnic University · NCT06298136 · Data updated 2026-11-12

This study tests whether an online mindfulness program can help children with ADHD feel better and also support their parents' mental health.

Quick facts

Study typeInterventional
SexAll
Enrollment208 (estimated)
SponsorThe Hong Kong Polytechnic University
Academic / other
Locations1 site (Hong Kong)
StatusRecruiting
StartedFebruary 1, 2024
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedMarch 18, 2025
Trial IDNCT06298136 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are parents of children aged 6 to 12 diagnosed with ADHD who are primary caregivers and speak Cantonese.

Probably not a fit

Patients with developmental disabilities, psychosis, or those who have previously completed an eight-week mindfulness-based intervention may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of an online mindfulness-based intervention designed for children diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD). The intervention aims to improve ADHD symptoms and enhance parental mental health through a randomized controlled trial format. Participants will include parents of children aged 6 to 12 who have been diagnosed with ADHD, focusing on those who have been primary caregivers and speak Cantonese. The study will assess the effectiveness of this online program in comparison to traditional behavioral interventions.

Why it matters

Potential benefit: If successful, this intervention could provide a valuable tool for improving ADHD symptoms in children while also supporting parental mental health.

How similar studies have gone: Previous studies have shown success with mindfulness-based interventions for ADHD, indicating potential for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* parents of children diagnosed with ADHD by a psychiatrist and psychologist according to the Diagnostic and Statistical Manual of Mental Disorders, 5th Ed (DSM-5)
* parents of children with ADHD aged 6 to 12.
* Parents who have served as the primary caregivers of their children in the last year and children with ADHD who speak and understand Cantonese Chinese.
* Children either not taking any medication or maintaining a stable dosage of the same ADHD medication for at least 3 months prior to study enrollment and having no plans to change medication and dosage during the study period.

Exclusion Criteria:

* parents diagnosed with developmental disabilities, psychosis, or cognitive impairment, who may thus have difficulty comprehending the content of the project.
* Children with another developmental disability such as autistic spectrum disorder or intellectual disability.
* Parents who completed an eight-week MBI or equivalent program.

Where it's running

  • Herman Hay Ming Lo
    Hong Kong, Hong Kong
    Recruiting

Study contacts

  • Principal investigator: Herman Hay Ming Lo, PhD — The Hong Kong Polytechnic University
  • Study coordinator: Herman Hay Ming Lo, PhD
  • Email: herman.lo@polyu.edu.hk
  • Phone: +85296279830

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.